Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Perrigo Company PLC v. Mylan N.V.
Case Number:
1:15-cv-07341
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 20, 2015
Mylan, Perrigo Settle Suit After $27B Hostile Takeover Row
Mylan and fellow generic-drug maker Perrigo told a New York federal court Friday they had settled a suit in which Mylan was accused of misleading Perrigo investors in a failed $27 billion hostile takeover attempt, after too few investors agreed to tender their shares last week.
-
October 19, 2015
Perrigo, Mylan Want Retractions In $27B Hostile Bid Fight
Mylan and Irish drugmaker Perrigo each accused the other of making false and misleading statements related to a hostile $27 billion tender offer from Mylan, making dueling filings in New York federal court to force each other to retract those statements.
-
September 22, 2015
Mylan Countersues Perrigo Over $27B Hostile Takeover Bid
Mylan NV on Tuesday launched counterclaims against Irish drugmaker Perrigo Co. PLC on Tuesday in New York federal court, claiming it has made "serious misstatements" in an effort to sway Perrigo shareholders into rejecting a tender offer worth about $27 billion.
-
September 17, 2015
Perrigo Rejects Mylan Offer Again, Files Suit
Irish drugmaker Perrigo Co. PLC on Thursday urged its shareholders not to accept a tender offer from Mylan Pharmaceuticals Inc. worth about $35.6 billion, and filed a lawsuit in New York federal court accusing Mylan of misleading investors.